{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T22:07:30Z","timestamp":1793052450308,"version":"4.5.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,4,23]],"date-time":"2018-04-23T00:00:00Z","timestamp":1524441600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,4,23]],"date-time":"2018-04-23T00:00:00Z","timestamp":1524441600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Massachusetts Alzheimer\u2019s Disease Research Center"},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AG046275"],"award-info":[{"award-number":["AG046275"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006312","name":"BrightFocus Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006312","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neuropathol"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1007\/s00401-018-1846-7","type":"journal-article","created":{"date-parts":[[2018,4,23]],"date-time":"2018-04-23T00:43:59Z","timestamp":1524444239000},"page":"19-40","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":162,"title":["Diffusible, highly bioactive oligomers represent a critical minority of soluble A\u03b2 in Alzheimer\u2019s disease brain"],"prefix":"10.1007","volume":"136","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0718-6261","authenticated-orcid":false,"given":"Wei","family":"Hong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zemin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiernan T.","family":"O\u2019Malley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8784-8105","authenticated-orcid":false,"given":"Michael","family":"Willem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Haass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew P.","family":"Frosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominic M.","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,23]]},"reference":[{"key":"1846_CR1","doi-asserted-by":"publisher","first-page":"7259","DOI":"10.1523\/JNEUROSCI.6500-10.2011","volume":"31","author":"AE Barry","year":"2011","unstructured":"Barry AE, Klyubin I, Mc Donald JM, Mably AJ, Farrell MA, Scott M, Walsh DM, Rowan MJ (2011) Alzheimer\u2019s disease brain-derived amyloid-beta-mediated inhibition of LTP in vivo is prevented by immunotargeting cellular prion protein. J Neurosci 31:7259\u20137263","journal-title":"J Neurosci"},{"key":"1846_CR2","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/nn.3028","volume":"15","author":"I Benilova","year":"2012","unstructured":"Benilova I, Karran E, De Strooper B (2012) The toxic Abeta oligomer and Alzheimer\u2019s disease: an emperor in need of clothes. Nat Neurosci 15:349\u2013357","journal-title":"Nat Neurosci"},{"key":"1846_CR3","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1016\/j.neurobiolaging.2012.10.028","volume":"34","author":"GG Borlikova","year":"2013","unstructured":"Borlikova GG, Trejo M, Mably AJ, Mc Donald JM, Sala Frigerio C, Regan CM, Murphy KJ, Masliah E, Walsh DM (2013) Alzheimer brain-derived amyloid beta-protein impairs synaptic remodeling and memory consolidation. Neurobiol Aging 34:1315\u20131327","journal-title":"Neurobiol Aging"},{"key":"1846_CR4","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s13195-017-0293-3","volume":"9","author":"DL Brody","year":"2017","unstructured":"Brody DL, Jiang H, Wildburger N, Esparza TJ (2017) Non-canonical soluble amyloid-beta aggregates and plaque buffering: controversies and future directions for target discovery in Alzheimer\u2019s disease. Alzheimers Res Ther 9:62","journal-title":"Alzheimers Res Ther"},{"key":"1846_CR5","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1016\/j.neurobiolaging.2007.02.029","volume":"29","author":"FG De Felice","year":"2008","unstructured":"De Felice FG, Wu D, Lambert MP, Fernandez SJ, Velasco PT, Lacor PN, Bigio EH, Jerecic J, Acton PJ, Shughrue PJ, Chen-Dodson E, Kinney GG, Klein WL (2008) Alzheimer\u2019s disease-type neuronal tau hyperphosphorylation induced by A beta oligomers. Neurobiol Aging 29:1334\u20131347","journal-title":"Neurobiol Aging"},{"key":"1846_CR6","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/S0002-9440(10)65273-X","volume":"154","author":"M Enya","year":"1999","unstructured":"Enya M, Morishima-Kawashima M, Yoshimura M, Shinkai Y, Kusui K, Khan K, Games D, Schenk D, Sugihara S, Yamaguchi H, Ihara Y (1999) Appearance of sodium dodecyl sulfate-stable amyloid beta-protein (Abeta) dimer in the cortex during aging. Am J Pathol 154:271\u2013279","journal-title":"Am J Pathol"},{"key":"1846_CR7","doi-asserted-by":"publisher","first-page":"38187","DOI":"10.1038\/srep38187","volume":"6","author":"TJ Esparza","year":"2016","unstructured":"Esparza TJ, Wildburger NC, Jiang H, Gangolli M, Cairns NJ, Bateman RJ, Brody DL (2016) Soluble amyloid-beta aggregates from human Alzheimer\u2019s disease brains. Sci Rep 6:38187","journal-title":"Sci Rep"},{"key":"1846_CR8","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1002\/ana.23748","volume":"73","author":"TJ Esparza","year":"2013","unstructured":"Esparza TJ, Zhao H, Cirrito JR, Cairns NJ, Bateman RJ, Holtzman DM, Brody DL (2013) Amyloid-beta oligomerization in Alzheimer dementia versus high-pathology controls. Ann Neurol 73:104\u2013119","journal-title":"Ann Neurol"},{"key":"1846_CR9","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/ncomms1341","volume":"2","author":"DB Freir","year":"2011","unstructured":"Freir DB, Nicoll AJ, Klyubin I, Panico S, Mc Donald JM, Risse E, Asante EA, Farrow MA, Sessions RB, Saibil HR, Clarke AR, Rowan MJ, Walsh DM, Collinge J (2011) Interaction between prion protein and toxic amyloid beta assemblies can be therapeutically targeted at multiple sites. Nat Commun 2:336","journal-title":"Nat Commun"},{"key":"1846_CR10","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S0002-9440(10)65094-8","volume":"155","author":"H Funato","year":"1999","unstructured":"Funato H, Enya M, Yoshimura M, Morishima-Kawashima M, Ihara Y (1999) Presence of sodium dodecyl sulfate-stable amyloid beta-protein dimers in the hippocampus CA1 not exhibiting neurofibrillary tangle formation. Am J Pathol 155:23\u201328","journal-title":"Am J Pathol"},{"key":"1846_CR11","doi-asserted-by":"publisher","first-page":"29639","DOI":"10.1074\/jbc.R800016200","volume":"283","author":"CG Glabe","year":"2008","unstructured":"Glabe CG (2008) Structural classification of toxic amyloid oligomers. J Biol Chem 283:29639\u201329643","journal-title":"J Biol Chem"},{"key":"1846_CR12","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/alzrt233","volume":"6","author":"TE Golde","year":"2014","unstructured":"Golde TE (2014) Open questions for Alzheimer\u2019s disease immunotherapy. Alzheimers Res Ther 6:3","journal-title":"Alzheimers Res Ther"},{"key":"1846_CR13","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.neuron.2011.01.002","volume":"69","author":"TE Golde","year":"2011","unstructured":"Golde TE, Schneider LS, Koo EH (2011) Anti-abeta therapeutics in Alzheimer\u2019s disease: the need for a paradigm shift. Neuron 69:203\u2013213","journal-title":"Neuron"},{"key":"1846_CR14","doi-asserted-by":"publisher","first-page":"3336","DOI":"10.1093\/brain\/awq277","volume":"133","author":"CR Jack Jr","year":"2010","unstructured":"Jack CR Jr, Wiste HJ, Vemuri P, Weigand SD, Senjem ML, Zeng G, Bernstein MA, Gunter JL, Pankratz VS, Aisen PS, Weiner MW, Petersen RC, Shaw LM, Trojanowski JQ, Knopman DS, ADNI (2010) Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer\u2019s disease. Brain 133:3336\u20133348","journal-title":"Brain"},{"key":"1846_CR15","doi-asserted-by":"publisher","first-page":"8585","DOI":"10.1074\/jbc.M110.172411","volume":"286","author":"A Jan","year":"2011","unstructured":"Jan A, Adolfsson O, Allaman I, Buccarello AL, Magistretti PJ, Pfeifer A, Muhs A, Lashuel HA (2011) Abeta42 neurotoxicity is mediated by ongoing nucleated polymerization process rather than by discrete Abeta42 species. J Biol Chem 286:8585\u20138596","journal-title":"J Biol Chem"},{"key":"1846_CR16","doi-asserted-by":"crossref","unstructured":"Jin M, O\u2019Nuallain B, Hong W, Boyd JD, Lagomarsino VN, O\u2019Malley TT, Liu W, Vanderburg CR, Frosch MP, Young-Pearse TL, Selkoe DJ, Walsh DM (2018) A new paradigm to assess the therapeutic potential of anti-A\u03b2 antibodies for Alzheimer\u2019s disease. (submitted)","DOI":"10.1038\/s41467-018-05068-w"},{"key":"1846_CR17","doi-asserted-by":"publisher","first-page":"5819","DOI":"10.1073\/pnas.1017033108","volume":"108","author":"M Jin","year":"2011","unstructured":"Jin M, Shepardson N, Yang T, Chen G, Walsh D, Selkoe DJ (2011) Soluble amyloid beta-protein dimers isolated from Alzheimer cortex directly induce Tau hyperphosphorylation and neuritic degeneration. Proc Natl Acad Sci USA 108:5819\u20135824","journal-title":"Proc Natl Acad Sci USA"},{"key":"1846_CR18","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1073\/pnas.94.4.1550","volume":"94","author":"K Johnson-Wood","year":"1997","unstructured":"Johnson-Wood K, Lee M, Motter R, Hu K, Gordon G, Barbour R, Khan K, Gordon M, Tan H, Games D, Lieberburg I, Schenk D, Seubert P, McConlogue L (1997) Amyloid precursor protein processing and A beta42 deposition in a transgenic mouse model of Alzheimer disease. Proc Natl Acad Sci USA 94:1550\u20131555","journal-title":"Proc Natl Acad Sci USA"},{"key":"1846_CR19","doi-asserted-by":"publisher","first-page":"8060","DOI":"10.1073\/pnas.87.20.8060","volume":"87","author":"KR Jones","year":"1990","unstructured":"Jones KR, Reichardt LF (1990) Molecular cloning of a human gene that is a member of the nerve growth factor family. Proc Natl Acad Sci USA 87:8060\u20138064","journal-title":"Proc Natl Acad Sci USA"},{"key":"1846_CR20","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1084\/jem.20121274","volume":"209","author":"J Kim","year":"2012","unstructured":"Kim J, Eltorai AE, Jiang H, Liao F, Verghese PB, Kim J, Stewart FR, Basak JM, Holtzman DM (2012) Anti-apoE immunotherapy inhibits amyloid accumulation in a transgenic mouse model of Abeta amyloidosis. J Exp Med 209:2149\u20132156","journal-title":"J Exp Med"},{"key":"1846_CR21","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/1756-6606-5-25","volume":"5","author":"I Klyubin","year":"2012","unstructured":"Klyubin I, Cullen WK, Hu NW, Rowan MJ (2012) Alzheimer\u2019s disease Abeta assemblies mediating rapid disruption of synaptic plasticity and memory. Mol Brain 5:25","journal-title":"Mol Brain"},{"key":"1846_CR22","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/nm1234","volume":"11","author":"I Klyubin","year":"2005","unstructured":"Klyubin I, Walsh DM, Lemere CA, Cullen WK, Shankar GM, Betts V, Spooner ET, Jiang L, Anwyl R, Selkoe DJ, Rowan MJ (2005) Amyloid beta protein immunotherapy neutralizes Abeta oligomers that disrupt synaptic plasticity in vivo. Nat Med 11:556\u2013561","journal-title":"Nat Med"},{"key":"1846_CR23","doi-asserted-by":"publisher","first-page":"4077","DOI":"10.1074\/jbc.271.8.4077","volume":"271","author":"YM Kuo","year":"1996","unstructured":"Kuo YM, Emmerling MR, Vigo-Pelfrey C, Kasunic TC, Kirkpatrick JB, Murdoch GH, Ball MJ, Roher AE (1996) Water-soluble Abeta (N-40, N-42) oligomers in normal and Alzheimer disease brains. J Biol Chem 271:4077\u20134081","journal-title":"J Biol Chem"},{"key":"1846_CR24","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/alzrt246","volume":"6","author":"L Lannfelt","year":"2014","unstructured":"Lannfelt L, Moller C, Basun H, Osswald G, Sehlin D, Satlin A, Logovinsky V, Gellerfors P (2014) Perspectives on future Alzheimer therapies: amyloid-beta protofibrils\u2014a new target for immunotherapy with BAN2401 in Alzheimer\u2019s disease. Alzheimers Res Ther 6:16","journal-title":"Alzheimers Res Ther"},{"key":"1846_CR25","doi-asserted-by":"publisher","first-page":"22122","DOI":"10.1074\/jbc.M111.236257","volume":"286","author":"CA Lasagna-Reeves","year":"2011","unstructured":"Lasagna-Reeves CA, Glabe CG, Kayed R (2011) Amyloid-beta annular protofibrils evade fibrillar fate in Alzheimer disease brain. J Biol Chem 286:22122\u201322130","journal-title":"J Biol Chem"},{"key":"1846_CR26","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1016\/j.celrep.2015.05.021","volume":"11","author":"P Liu","year":"2015","unstructured":"Liu P, Reed MN, Kotilinek LA, Grant MK, Forster CL, Qiang W, Shapiro SL, Reichl JH, Chiang AC, Jankowsky JL, Wilmot CM, Cleary JP, Zahs KR, Ashe KH (2015) Quaternary structure defines a large class of amyloid-beta oligomers neutralized by sequestration. Cell Rep 11:1760\u20131771","journal-title":"Cell Rep"},{"key":"1846_CR27","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/S0002-9440(10)65184-X","volume":"155","author":"LF Lue","year":"1999","unstructured":"Lue LF, Kuo YM, Roher AE, Brachova L, Shen Y, Sue L, Beach T, Kurth JH, Rydel RE, Rogers J (1999) Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer\u2019s disease. Am J Pathol 155:853\u2013862","journal-title":"Am J Pathol"},{"key":"1846_CR28","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.nbd.2015.07.008","volume":"82","author":"AJ Mably","year":"2015","unstructured":"Mably AJ, Liu W, Mc Donald JM, Dodart JC, Bard F, Lemere CA, O\u2019Nuallain B, Walsh DM (2015) Anti-Abeta antibodies incapable of reducing cerebral Abeta oligomers fail to attenuate spatial reference memory deficits in J20 mice. Neurobiol Dis 82:372\u2013384","journal-title":"Neurobiol Dis"},{"key":"1846_CR29","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1016\/j.jalz.2015.01.005","volume":"11","author":"JM Mc Donald","year":"2015","unstructured":"Mc Donald JM, O\u2019Malley TT, Liu W, Mably AJ, Brinkmalm G, Portelius E, Wittbold WM 3rd, Frosch MP, Walsh DM (2015) The aqueous phase of Alzheimer\u2019s disease brain contains assemblies built from approximately 4 and approximately 7\u00a0kDa Abeta species. Alzheimers Dement 11:1286\u20131305","journal-title":"Alzheimers Dement"},{"key":"1846_CR30","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1093\/brain\/awq065","volume":"133","author":"JM Mc Donald","year":"2010","unstructured":"Mc Donald JM, Savva GM, Brayne C, Welzel AT, Forster G, Shankar GM, Selkoe DJ, Ince PG, Walsh DM (2010) The presence of sodium dodecyl sulphate-stable Abeta dimers is strongly associated with Alzheimer-type dementia. Brain 133:1328\u20131341","journal-title":"Brain"},{"key":"1846_CR31","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.brainres.2012.02.041","volume":"1450","author":"JM McDonald","year":"2012","unstructured":"McDonald JM, Cairns NJ, Taylor-Reinwald L, Holtzman D, Walsh DM (2012) The levels of water-soluble and triton-soluble Abeta are increased in Alzheimer\u2019s disease brain. Brain Res 1450:138\u2013147","journal-title":"Brain Res"},{"key":"1846_CR32","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1038\/nm790","volume":"8","author":"J McLaurin","year":"2002","unstructured":"McLaurin J, Cecal R, Kierstead ME, Tian X, Phinney AL, Manea M, French JE, Lambermon MH, Darabie AA, Brown ME, Janus C, Chishti MA, Horne P, Westaway D, Fraser PE, Mount HT, Przybylski M, St George-Hyslop P (2002) Therapeutically effective antibodies against amyloid-beta peptide target amyloid-beta residues 4\u201310 and inhibit cytotoxicity and fibrillogenesis. Nat Med 8:1263\u20131269","journal-title":"Nat Med"},{"key":"1846_CR33","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1002\/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M","volume":"46","author":"CA McLean","year":"1999","unstructured":"McLean CA, Cherny RA, Fraser FW, Fuller SJ, Smith MJ, Beyreuther K, Bush AI, Masters CL (1999) Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer\u2019s disease. Ann Neurol 46:860\u2013866","journal-title":"Ann Neurol"},{"key":"1846_CR34","doi-asserted-by":"publisher","first-page":"32895","DOI":"10.1074\/jbc.M109.000208","volume":"284","author":"A Noguchi","year":"2009","unstructured":"Noguchi A, Matsumura S, Dezawa M, Tada M, Yanazawa M, Ito A, Akioka M, Kikuchi S, Sato M, Ideno S, Noda M, Fukunari A, Muramatsu S, Itokazu Y, Sato K, Takahashi H, Teplow DB, Nabeshima Y, Kakita A, Imahori K, Hoshi M (2009) Isolation and characterization of patient-derived, toxic, high mass amyloid beta-protein (Abeta) assembly from Alzheimer disease brains. J Biol Chem 284:32895\u201332905","journal-title":"J Biol Chem"},{"key":"1846_CR35","doi-asserted-by":"publisher","first-page":"6338","DOI":"10.1073\/pnas.86.16.6338","volume":"86","author":"MR Palmert","year":"1989","unstructured":"Palmert MR, Podlisny MB, Witker DS, Oltersdorf T, Younkin LH, Selkoe DJ, Younkin SG (1989) The beta-amyloid protein precursor of Alzheimer disease has soluble derivatives found in human brain and cerebrospinal fluid. Proc Natl Acad Sci USA 86:6338\u20136342","journal-title":"Proc Natl Acad Sci USA"},{"key":"1846_CR36","doi-asserted-by":"publisher","first-page":"9564","DOI":"10.1074\/jbc.270.16.9564","volume":"270","author":"MB Podlisny","year":"1995","unstructured":"Podlisny MB, Ostaszewski BL, Squazzo SL, Koo EH, Rydell RE, Teplow DB, Selkoe DJ (1995) Aggregation of secreted amyloid beta-protein into sodium dodecyl sulfate-stable oligomers in cell culture. J Biol Chem 270:9564\u20139570","journal-title":"J Biol Chem"},{"key":"1846_CR37","doi-asserted-by":"publisher","first-page":"20631","DOI":"10.1074\/jbc.271.34.20631","volume":"271","author":"AE Roher","year":"1996","unstructured":"Roher AE, Chaney MO, Kuo YM, Webster SD, Stine WB, Haverkamp LJ, Woods AS, Cotter RJ, Tuohy JM, Krafft GA, Bonnell BS, Emmerling MR (1996) Morphology and toxicity of Abeta-(1-42) dimer derived from neuritic and vascular amyloid deposits of Alzheimer\u2019s disease. J Biol Chem 271:20631\u201320635","journal-title":"J Biol Chem"},{"key":"1846_CR38","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1111\/j.1742-4658.2010.07579.x","volume":"277","author":"C Sala Frigerio","year":"2010","unstructured":"Sala Frigerio C, Fadeeva JV, Minogue AM, Citron M, Van Leuven F, Staufenbiel M, Paganetti P, Selkoe DJ, Walsh DM (2010) beta-Secretase cleavage is not required for generation of the intracellular C-terminal domain of the amyloid precursor family of proteins. FEBS J 277:1503\u20131518","journal-title":"FEBS J"},{"key":"1846_CR39","doi-asserted-by":"publisher","first-page":"e32014","DOI":"10.1371\/journal.pone.0032014","volume":"7","author":"D Sehlin","year":"2012","unstructured":"Sehlin D, Englund H, Simu B, Karlsson M, Ingelsson M, Nikolajeff F, Lannfelt L, Pettersson FE (2012) Large aggregates are the major soluble Abeta species in AD brain fractionated with density gradient ultracentrifugation. PLoS ONE 7:e32014","journal-title":"PLoS ONE"},{"key":"1846_CR40","doi-asserted-by":"publisher","first-page":"595","DOI":"10.15252\/emmm.201606210","volume":"8","author":"DJ Selkoe","year":"2016","unstructured":"Selkoe DJ, Hardy J (2016) The amyloid hypothesis of Alzheimer\u2019s disease at 25\u00a0years. EMBO Mol Med 8:595\u2013608","journal-title":"EMBO Mol Med"},{"key":"1846_CR41","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/359325a0","volume":"359","author":"P Seubert","year":"1992","unstructured":"Seubert P, Vigo-Pelfrey C, Esch F, Lee M, Dovey H, Davis D, Sinha S, Schlossmacher M, Whaley J, Swindlehurst C et al (1992) Isolation and quantification of soluble Alzheimer\u2019s beta-peptide from biological fluids. Nature 359:325\u2013327","journal-title":"Nature"},{"key":"1846_CR42","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1038\/nm1782","volume":"14","author":"GM Shankar","year":"2008","unstructured":"Shankar GM, Li S, Mehta TH, Garcia-Munoz A, Shepardson NE, Smith I, Brett FM, Farrell MA, Rowan MJ, Lemere CA, Regan CM, Walsh DM, Sabatini BL, Selkoe DJ (2008) Amyloid-beta protein dimers isolated directly from Alzheimer\u2019s brains impair synaptic plasticity and memory. Nat Med 14:837\u2013842","journal-title":"Nat Med"},{"key":"1846_CR43","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/1750-1326-4-48","volume":"4","author":"GM Shankar","year":"2009","unstructured":"Shankar GM, Walsh DM (2009) Alzheimer\u2019s disease: synaptic dysfunction and Abeta. Mol Neurodegener 4:48","journal-title":"Mol Neurodegener"},{"key":"1846_CR44","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/978-1-60761-744-0_3","volume":"670","author":"GM Shankar","year":"2011","unstructured":"Shankar GM, Welzel AT, McDonald JM, Selkoe DJ, Walsh DM (2011) Isolation of low-n amyloid beta-protein oligomers from cultured cells, CSF, and brain. Methods Mol Biol 670:33\u201344","journal-title":"Methods Mol Biol"},{"key":"1846_CR45","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/0014-5793(88)80200-X","volume":"237","author":"J Simpson","year":"1988","unstructured":"Simpson J, Bladon CM, Yates CM, Harmar AJ (1988) An antiserum to the C-terminus of the Alzheimer amyloid precursor recognizes a soluble 70\u00a0kDa protein. FEBS Lett 237:196\u2013198","journal-title":"FEBS Lett"},{"key":"1846_CR46","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.nlm.2012.03.007","volume":"97","author":"L Sui","year":"2012","unstructured":"Sui L, Wang Y, Ju LH, Chen M (2012) Epigenetic regulation of reelin and brain-derived neurotrophic factor genes in long-term potentiation in rat medial prefrontal cortex. Neurobiol Learn Mem 97:425\u2013440","journal-title":"Neurobiol Learn Mem"},{"key":"1846_CR47","doi-asserted-by":"publisher","first-page":"14673","DOI":"10.1021\/jacs.5b07849","volume":"137","author":"O Szczepankiewicz","year":"2015","unstructured":"Szczepankiewicz O, Linse B, Meisl G, Thulin E, Frohm B, Sala Frigerio C, Colvin MT, Jacavone AC, Griffin RG, Knowles T, Walsh DM, Linse S (2015) N-terminal extensions retard Abeta42 fibril formation but allow cross-seeding and coaggregation with Abeta42. J Am Chem Soc 137:14673\u201314685","journal-title":"J Am Chem Soc"},{"key":"1846_CR48","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1038\/nn.3178","volume":"15","author":"JW Um","year":"2012","unstructured":"Um JW, Nygaard HB, Heiss JK, Kostylev MA, Stagi M, Vortmeyer A, Wisniewski T, Gunther EC, Strittmatter SM (2012) Alzheimer amyloid-beta oligomer bound to postsynaptic prion protein activates Fyn to impair neurons. Nat Neurosci 15:1227\u20131235","journal-title":"Nat Neurosci"},{"key":"1846_CR49","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1111\/j.1582-4934.2011.01306.x","volume":"16","author":"AR Upadhaya","year":"2012","unstructured":"Upadhaya AR, Lungrin I, Yamaguchi H, Fandrich M, Thal DR (2012) High-molecular weight Abeta oligomers and protofibrils are the predominant Abeta species in the native soluble protein fraction of the AD brain. J Cell Mol Med 16:287\u2013295","journal-title":"J Cell Mol Med"},{"key":"1846_CR50","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s00401-015-1386-3","volume":"129","author":"KL Viola","year":"2015","unstructured":"Viola KL, Klein WL (2015) Amyloid beta oligomers in Alzheimer\u2019s disease pathogenesis, treatment, and diagnosis. Acta Neuropathol 129:183\u2013206","journal-title":"Acta Neuropathol"},{"key":"1846_CR51","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.neuron.2004.09.010","volume":"44","author":"DM Walsh","year":"2004","unstructured":"Walsh DM, Selkoe DJ (2004) Deciphering the molecular basis of memory failure in Alzheimer\u2019s disease. Neuron 44:181\u2013193","journal-title":"Neuron"},{"key":"1846_CR52","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/B978-0-12-385883-2.00012-6","volume":"107","author":"DM Walsh","year":"2012","unstructured":"Walsh DM, Teplow DB (2012) Alzheimer\u2019s disease and the amyloid beta-protein. Prog Mol Biol Transl Sci 107:101\u2013124","journal-title":"Prog Mol Biol Transl Sci"},{"key":"1846_CR53","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1006\/exnr.1999.7085","volume":"158","author":"J Wang","year":"1999","unstructured":"Wang J, Dickson DW, Trojanowski JQ, Lee VM (1999) The levels of soluble versus insoluble brain Abeta distinguish Alzheimer\u2019s disease from normal and pathologic aging. Exp Neurol 158:328\u2013337","journal-title":"Exp Neurol"},{"key":"1846_CR54","doi-asserted-by":"publisher","first-page":"11947","DOI":"10.1523\/JNEUROSCI.2009-17.2017","volume":"37","author":"Z Wang","year":"2017","unstructured":"Wang Z, Jackson RJ, Hong W, Taylor WM, Corbett GT, Moreno A, Liu W, Li S, Frosch MP, Slutsky I, Young-Pearse TL, Spires-Jones TL, Walsh DM (2017) Human brain-derived abeta oligomers bind to synapses and disrupt synaptic activity in a manner that requires APP. J Neurosci 37:11947\u201311966","journal-title":"J Neurosci"},{"key":"1846_CR55","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1179\/016164105X49436","volume":"27","author":"D Watson","year":"2005","unstructured":"Watson D, Castano E, Kokjohn TA, Kuo YM, Lyubchenko Y, Pinsky D, Connolly ES Jr, Esh C, Luehrs DC, Stine WB, Rowse LM, Emmerling MR, Roher AE (2005) Physicochemical characteristics of soluble oligomeric Abeta and their pathologic role in Alzheimer\u2019s disease. Neurol Res 27:869\u2013881","journal-title":"Neurol Res"},{"key":"1846_CR56","doi-asserted-by":"publisher","first-page":"3908","DOI":"10.1021\/bi5003053","volume":"53","author":"AT Welzel","year":"2014","unstructured":"Welzel AT, Maggio JE, Shankar GM, Walker DE, Ostaszewski BL, Li S, Klyubin I, Rowan MJ, Seubert P, Walsh DM, Selkoe DJ (2014) Secreted amyloid beta-proteins in a cell culture model include N-terminally extended peptides that impair synaptic plasticity. Biochemistry 53:3908\u20133921","journal-title":"Biochemistry"},{"key":"1846_CR57","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/nature14864","volume":"526","author":"M Willem","year":"2015","unstructured":"Willem M, Tahirovic S, Busche MA, Ovsepian SV, Chafai M, Kootar S, Hornburg D, Evans LD, Moore S, Daria A, Hampel H, Muller V, Giudici C, Nuscher B, Wenninger-Weinzierl A, Kremmer E, Heneka MT, Thal DR, Giedraitis V, Lannfelt L, Muller U, Livesey FJ, Meissner F, Herms J, Konnerth A, Marie H, Haass C (2015) eta-Secretase processing of APP inhibits neuronal activity in the hippocampus. Nature 526:443\u2013447","journal-title":"Nature"},{"key":"1846_CR58","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1523\/JNEUROSCI.2381-04.2005","volume":"25","author":"M Wogulis","year":"2005","unstructured":"Wogulis M, Wright S, Cunningham D, Chilcote T, Powell K, Rydel RE (2005) Nucleation-dependent polymerization is an essential component of amyloid-mediated neuronal cell death. J Neurosci 25:1071\u20131080","journal-title":"J Neurosci"},{"key":"1846_CR59","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1523\/JNEUROSCI.1698-16.2016","volume":"37","author":"T Yang","year":"2017","unstructured":"Yang T, Li S, Xu H, Walsh DM, Selkoe DJ (2017) Large soluble oligomers of amyloid beta-protein from Alzheimer brain are far less neuroactive than the smaller oligomers to which they dissociate. J Neurosci 37:152\u2013163","journal-title":"J Neurosci"},{"key":"1846_CR60","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13195-015-0100-y","volume":"7","author":"T Yang","year":"2015","unstructured":"Yang T, O\u2019Malley TT, Kanmert D, Jerecic J, Zieske LR, Zetterberg H, Hyman BT, Walsh DM, Selkoe DJ (2015) A highly sensitive novel immunoassay specifically detects low levels of soluble Abeta oligomers in human cerebrospinal fluid. Alzheimers Res Ther 7:14","journal-title":"Alzheimers Res Ther"},{"key":"1846_CR61","doi-asserted-by":"publisher","first-page":"4755","DOI":"10.1074\/jbc.R800018200","volume":"284","author":"BA Yankner","year":"2009","unstructured":"Yankner BA, Lu T (2009) Amyloid beta-protein toxicity and the pathogenesis of Alzheimer disease. J Biol Chem 284:4755\u20134759","journal-title":"J Biol Chem"},{"key":"1846_CR62","doi-asserted-by":"publisher","first-page":"e11853","DOI":"10.1371\/journal.pone.0011853","volume":"5","author":"H Zeng","year":"2010","unstructured":"Zeng H, Guo M, Martins-Taylor K, Wang X, Zhang Z, Park JW, Zhan S, Kronenberg MS, Lichtler A, Liu HX, Chen FP, Yue L, Li XJ, Xu RH (2010) Specification of region-specific neurons including forebrain glutamatergic neurons from human induced pluripotent stem cells. PLoS ONE 5:e11853","journal-title":"PLoS ONE"},{"key":"1846_CR63","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.neuron.2013.05.029","volume":"78","author":"Y Zhang","year":"2013","unstructured":"Zhang Y, Pak C, Han Y, Ahlenius H, Zhang Z, Chanda S, Marro S, Patzke C, Acuna C, Covy J, Xu W, Yang N, Danko T, Chen L, Wernig M, Sudhof TC (2013) Rapid single-step induction of functional neurons from human pluripotent stem cells. Neuron 78:785\u2013798","journal-title":"Neuron"}],"container-title":["Acta Neuropathologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00401-018-1846-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-018-1846-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-018-1846-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T08:50:03Z","timestamp":1589619003000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00401-018-1846-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,23]]},"references-count":63,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["1846"],"URL":"https:\/\/doi.org\/10.1007\/s00401-018-1846-7","relation":{},"ISSN":["0001-6322","1432-0533"],"issn-type":[{"value":"0001-6322","type":"print"},{"value":"1432-0533","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,23]]},"assertion":[{"value":"31 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}